Azar Taps Nat’l Cancer Institute Director As Acting FDA Commissioner

By David Roza / March 12, 2019 at 3:31 PM
National Cancer Institute Director Ned Sharpless will become acting commissioner of FDA when current Commissioner Scott Gottlieb resigns in early April, HHS Secretary Alex Azar announced at a House hearing Tuesday (March 12). Sharpless was among three candidates viewed as top contenders for the job, and Azar said Sharpless’ “deep scientific background and expertise will make him a strong leader for FDA,” he said. “There will be no let-up in the agency’s focus, from ongoing efforts on drug approvals and...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.